Protein Carbonylation in Patients with Myelodysplastic Syndrome: An Opportunity for Deferasirox Therapy

• Asıl Yazarlar: Alba Rodríguez-García (Yazar), María Luz Morales (Yazar), Vanesa Garrido-García (Yazar), Irene García-Baquero (Yazar), Alejandra Leivas (Yazar), Gonzalo Carreño-Tarragona (Yazar), Ricardo Sánchez (Yazar), Alicia Arenas (Yazar), Teresa Cedena (Yazar), Rosa María Ayala (Yazar), José M. Bautista (Yazar), Joaquín Martínez-López (Yazar), María Linares (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2019-10-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Control of oxidative stress in the bone marrow (BM) is key for maintaining the interplay between self-renewal, proliferation, and differentiation of hematopoietic cells. Breakdown of this regulation can lead to diseases characterized by BM failure such as the myelodysplastic syndromes (MDS). To bett...